Related Experiment Video
Updated: Apr 12, 2026

07:17
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
2.0K
Hirayama Disease: Latest Insights into an Intriguing Disorder
Dipti Baskar1, Atchayaram Nalini, Seena Vengalil
1Department of Neurology, National Institute of Mental Health and Neuro Sciences, Bengaluru, Karnataka, India.
Annals of Indian Academy of Neurology
|April 11, 2026
Summary
Hirayama disease (HD), a cervical myelopathy, causes upper limb weakness. Early diagnosis via dynamic MRI and surgical intervention like anterior cervical discectomy and fusion can prevent severe functional deficits.
Area of Science:
- Neurology
- Orthopedic Surgery
- Radiology
Background:
- Hirayama disease (HD) is a rare cervical myelopathy causing progressive, asymmetrical upper limb weakness.
- It typically affects adolescent males and leads to irreversible functional deficits over 3-5 years.
- Rarer phenotypes include distal bimelic amyotrophy and motor neuron variants.
Purpose of the Study:
- To review the latest insights into Hirayama disease pathophysiology.
- To discuss diagnostic imaging, including dynamic flexion MRI, and its findings.
- To explore management strategies, including conservative and surgical options for preventing limb weakness.
Main Methods:
- Review of current literature on Hirayama disease.
- Analysis of diagnostic criteria and imaging characteristics, particularly dynamic flexion MRI.
- Evaluation of surgical techniques and outcomes for managing progressive cases.
Main Results:
- Dynamic flexion MRI shows high sensitivity (93%) and specificity (98%) for HD diagnosis.
- Distinctive MRI findings include epidural flow voids and anterior dural sac displacement.
- Anterior cervical discectomy and fusion with plating is considered an ideal surgical approach.
Conclusions:
- Early diagnosis of Hirayama disease is crucial for effective management.
- Dynamic flexion MRI is a key diagnostic tool for identifying characteristic spinal cord changes.
- Surgical intervention, such as anterior cervical discectomy and fusion, may prevent severe residual limb weakness.
Keywords:
Hirayama diseasebrachial monomelic amyotrophycervical flexion induced myelopathydistal bimelic amyotrophydynamic magnetic resonance imagingmonomelic amyotrophyMore Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
754
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
754
Rheumatic Heart Disease I: Introduction
950
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
950
Translation
23.2K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
23.2K
Translation
162.4K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
162.4K
Hazard Ratio
731
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
731
Pedigree Analysis
91.3K
Overview
91.3K

